Testing colchicine for people with ALS
Treatments studied
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests whether the drug colchicine can help people with ALS. It aims to see if taking colchicine in addition to your usual riluzole treatment slows the progression of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 80 years.
- Diagnosis of ALS (sporadic or inherited).
- Currently taking riluzole (100 mg/day) for at least 1 month.
- Body mass index (BMI) above 17.5.
- Breathing function at least 70% of normal (for vital capacity).
- Able to give written informed consent and willing to use effective contraception.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a supplement called acetyl-L-carnitine (ALCAR) to see if it can slow the progression of ALS. It is for people in the early stages of the disease who are already taking riluzole and have good lung and muscle function.
This trial tests whether adding two supplements (EH-301 and N-acetylcysteine) to the standard ALS medicine Riluzole can help slow the disease. It is for people diagnosed with ALS within the last 18 months who still have good breathing and daily function.
This trial tests whether a medicine called cyclophosphamide can slow the progression of ALS. It's given to people who have had symptoms for less than 2 years and still have good breathing, to see if calming the immune system can help protect nerve cells.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
This study tests an experimental drug called PLL001 for people with ALS. It aims to see if the drug is safe and whether it can slow the progression of the disease.
This trial tests a new drug called TP04HN106 for people with ALS. It aims to see if it is safe and if it might slow down the disease. You may qualify if your breathing is still fairly good and you have been on a stable dose of riluzole.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.